![Zorbtive [somatropin (rDNA origin) for injection]](images/Zorbtive_180.png)
What defines SBS
Why SBS may need specialized treatment
Living with
parenteral nutrition
Zorbtive is the latest treatment advance
 |
| “I want to do everything possible to live the way I choose.” |
Generally speaking, you can lose about half the length or function of your small intestine, and the remaining small intestine will slowly increase its ability to absorb.
But, when two-thirds or more of your small intestine is removed or not functioning the way it should, what remains may not be able to absorb enough nutrients and fluids to maintain your body without help.
This condition is Short Bowel Syndrome (SBS).
This website is about a treatment advance for SBS.
It brings a message of hope to those who face this challenging condition:
- The understanding of SBS and the range of treatment options have increased in recent years
- Today, people with SBS have better prospects to live with less dependence on parenteral nutrition (PN), which may lead to an improved lifestyle
What defines SBS
Why SBS may need specialized treatment
Living with parenteral nutrition
Zorbtive is the latest treatment advance
Home
Zorbtive® [somatropin (rDNA origin) for injection] is indicated for the treatment of Short Bowel Syndrome (SBS) in patients receiving specialized nutritional support. Optimal management of SBS may include dietary adjustments, enteral feedings, parenteral nutrition, and fluid and micronutrient supplements, as needed.
Some common side effects of Zorbtive treatment include muscle and joint pain, and fluid retention (swelling).
Zorbtive may also cause serious side effects such as inflammation of the pancreas (pancreatitis), diabetes or
other blood sugar problems, pain, numbness or tingling in the wrist and hand, or increased blood pressure
in the brain. Make sure and talk with your doctor about these side effects.
Do not take Zorbtive if you have any of the following serious medical conditions: open-heart surgery; stomach-area (abdominal) surgery; an accident; breathing problems (respiratory failure); cancer; or, allergy to Zorbtive or other growth hormone medications.
This information is not intended to replace discussions with your healthcare professional.
For additional information about Zorbtive, please read the Zorbtive Patient Information Leaflet
and Zorbtive Full Prescribing Information and talk to your doctor. You can also call SeroCareSM
toll free at 800-714-2437. Zorbtive is available by prescription only.
This Web site was developed by EMD Serono, Inc. (emdserono.com), makers of Zorbtive, to educate SBS patients
and interested healthcare professionals about this treatment for Short Bowel Syndrome.
This site contains medical information that is intended for residents of the United States
only and is not meant to substitute for the advice provided by a medical professional.
Always consult a doctor if you have health concerns. Use and access of this
site is subject to the terms and conditions as set out in our Legal Statement
and Privacy Policy.
© 2007 EMD Serono, Inc. All rights reserved. 